Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-07-10
1998-03-31
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540465, 540472, 540145, 534 11, 534 15, 534 16, A61K 31715, C07D48722
Patent
active
057339031
ABSTRACT:
The present invention relates to the use of water-soluble texaphyrin-diamagnetic metal complexes retaining lipophilicity as photosensitizers in the treatment of benign and malignant neoplastic tissue.
REFERENCES:
patent: 3920692 (1975-11-01), Wiersdorff et al.
patent: 5250668 (1993-10-01), Morgan et al.
patent: 5252720 (1993-10-01), Sessler et al.
patent: 5257970 (1993-11-01), Dougherty
patent: 5457183 (1995-10-01), Sessler et al.
patent: 5559207 (1996-09-01), Sessler et al.
Maiya et al. J. Phy.Chem. 1989, 93, p. 8111-8115.
Sessle et al., Topics in Current Chemistry, vol. 161, p. 205.
Sessler and Burrell, "Expanded Porphyrins," Topics in Current Chemistry, 161:180-273, 1991.
Sessler et al., "Synthesis and Structural Characterization of Lanthanide(III) Texaphyrins," Inorgnaic chemistry, 32(14):3175-3187, 1993.
Sessler, Jonathan L., "Texas-Sized Molecule," Discovery, 13(1):44-49, 1993.
Sessler et al., "Photodynamic Inactivation of Enveloped Viruses Using Sapphyrin, a 22 II-Electron Expanded Porphyrin: Possible Approaches to Prophylactic Blood Purificatiion Protocols," SPIE Photodynamic Therapy: Mechanisms II. 1203L233-245, 1990.
Maiya et al., "Ground-and Excited-State Spectral and Redox Properties of Cadmium(II) Texaphryrin," Journal of Physical Chemistry, 93(24) :8111-8115, 1989.
Sessler et al., "Texaphyrins: Synthesis and Applications," Accounts of Chemical Research, 27(2) :43-50, 1994.
Leff, "Texas `Son-of-Porphyrin` Molecule Lassos Europium to Kill Drug Resistance Gene," BioWorld Today, 5(156):1, 1994.
Young et al., "Preclinical Evaluation of Gadolinium (III) Texaphyrin Complex. A New Paramagnetic Contrast Agent for Magnetic Resonance Imaging," Investigative Radiology, 29(3) :330-338, 1994.
Furuta et al., "Enhanced Transport of Nucleosides and Nucleoside Analogues with Complementary Base-Pairing Agents,"Journal of the American Chemical Society, 113:4706-4707, 1991.
Sessler et al., "Anion Binding: A New Direction In Porphyrin-Related Research," Pure & Applied Chem., 65(3) :393-398, 1993.
Sessler et al., "Synthesis and Binding Properties of Monomeric and Dimeric Guanine and Cytosine Amine Derivatives," J. Org. Chem., 1992, 57:818-826.
T.D. Mody et al., "Lutetium (III) Texaphyrin: A Novel Photodynamic Therapy Agent," Abstract, 22nd Annual American Society for Photobiology, Scottsdale, AZ, Jun. 25-29, 1994.
Sessler et al., "Gadolinium (III) Texaphyrin: A Novel MRI Contrast Agent," Journal of the American Chemical Society, 115(22):10368-10369, 1993.
Iverson et al., "Interactions Between Expanded Porphyrins and Nucleic Acids," Pure Applied Chemistry, 66(4):845-850, 1994.
Magda et al., "Site-Specific Hydrolysis of RNA by Europium (III) Texaphyrin Conjugated to a Synthetic Oligodeoxyribonucleotide," Journal of the American Chemical Society, 116(16):7439-7440, 1994.
Koenig et al., "PDT of Tumor-Bearing Mice Using Liposome Delivered Texaphyrins," International Conference, Milan, Italy, biosis citation only, Jun. 24-27, 1992.
Mastruzzo et al., "Targeted Photochemical Modification of HIV-Derived Oligoribonucleotides by Antisense Oligodeoxynucleotides Linked to Porphyrins," Photochemistry and Photobiology, vol. 60, No. 4, pp. 316-322, 1994.
Magda et al., "Sequence-Specific Photocleavage of DNA by an Expanded Porphyrin with Irradiation Above 700 nm," J. Am. Chem. Soc., 117:3629-3630, 1995.
Sessler et al., "Expanded Porphyrins. Receptors for Cationic, Anionic, and Neutral Substrates," in Transition Metals in Supramolecular Chemistry, L. Fabbrizzi and A. Poggi, Editors, NATO ASI Series, Kluwer, Amsterdam, pp. 391-408, 1994.
PCT/US94/11491 International Search Report mailed Feb. 23, 1995.
PCT/US94/06284 International Search Report mailed Dec. 6, 1994.
PCT/US93/09994 International Search Report mailed Feb. 22, 1994.
PCT/US93/09994 International Search Report mailed Feb. 3, 1994.
Ehrenberg et al., "Spectroscopy, Photokinetics and Cellular Effect of FarRed and Near Infrared Absorbing Photosensitizers," Proc. SPIE-Int. Soc. Opt. Eng 1992, 1645 (Proc. Opt. Methods Tumor Treat. dect.: Mech. Tech. Photodyn. Ther. . . , 259-263, 1992.
Thaller et al., "Potential Use of Radiolabelled Porphyrins for Tumor Scanning," Porphyrin Photosensitization, Kessel and Dougherty, Eds., Plenum Press, New York and London, Publisher, pp. 265-278, 1981.
Brown and Truscott, "New Light on Cancer Therapy," Chemistry in Britain, 955-958, 1993.
Ehrenberg et al., "The Binding and Photosensitization Effects of Tetrabenzoporphyrins and Texaphyrin in Bacterial Cells," Lasers in Medical Science, 8:197-203, 1993.
Morgan and Skalkos, "Second Generation Sensitizers: Where are We and Where Should We Be Going?" Proc. SPIE Int. Soc. Opt. Eng. Ser., 6:87-106, 1990.
Horstman, "Study to examine skin cancer drug activated by light," Stanford University Campus Report, Mar. 1996.
Biolo, et al., "Photodynamic Therapy of B16 Pigmented Melanoma With Liposome-Delivered Si(IV)-Naphthalocyanine," Photochemistry and Photobiology, vol. 59, No. 3, pp. 362-265, 1994.
Haylett, et al., "Pharmacokinetic and therapeutic outcome in melanoma cells, of the administration of symmetric and asymmetric cationic photosensitizers," Cancer Letters 88, pp. 191-199, 1995.
Leunig, et al., "Tumour localisation kinetics of photofrin and three synthetic porphyrioids in an amelanotic melanoma of the hamster," Br. J. Cancer, 68, pp. 225-234, 1993.
Nelson, et al., "Photodynamic Therapy of Human Malignant Melanoma Xenografts in Athymic Nude Mice," Jurnal of the National Cancer Institute, vol. 80, No. 1, Mar. 2, 1988.
Sealy, et al., "Photosensitization of Melanin: An Electron Spin Resonance Study of Sensitized Radical Production and Oxygen Consumption," Photochemistry and Photobiology, vol. 40, No. 4, pp. 453-459, 1984.
Dialog Search, 1996.
PCT/US90/01208 International Search Report mailed Aug. 2, 1990.
PCT/US95/12312 International Search Report mailed Feb. 9, 1996.
Konig et al., "PDT of Tumor-Bearing Mice Using Liposome Delivered Texaphyrins", International Conference on Photodynamic Therapy and Medical Laser Applications, Milan, Italy, Photodynamic Therapy and Biomedical Lasers, ed. Spinelli et al., Elsevier Science Publishers B.V., pp. 802-805, 1992.
Konig et al., "Photodynamic Activity of Liposome-Delivered Cd-Texaphyrin Using Tumor-Bearing Nude Mice", Lasers in Surgery and Medicine 13:522-527, 1993.
Pharmacyclics' Press Release, "Pharmacyclics Expands Photodynamic Therapy Trial to Stanford," Mar. 28, 1996.
Fieser & Fieser, "Reagents for Organic Synthesis," John Wiley & Sons, Inc., vol. I, eratta sheet and p. 215, 1967.
PCT/US96/08262 International Search Report mailed Sep. 10, 1996.
Dialog Search, 1995.
Hemmi Gregory W.
Mody Tarak D.
Sessler Jonathan L.
Board of Regents , The University of Texas System
Larson Jacqueline S.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Treatment of neoplastic tissue by water-soluble texaphyrine meta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of neoplastic tissue by water-soluble texaphyrine meta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neoplastic tissue by water-soluble texaphyrine meta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52142